Precautions when using larotinib

Larotrectinib is a targeted therapy drug mainly used for cancer patients carrying NTRK (neuronal growth factor receptor kinase) gene fusion. When using larotrectinib, patients and doctors need to work closely and follow professional medication instructions. The following are some important considerations regarding larotrectinib:

1. Indications

Larotinib is mainly suitable for cancer patients carryingNTRK gene fusion, including but not limited to soft tissue sarcoma, infantile fibroma, lung cancer, etc. Before starting larotrectinib, patients often need genetic testing to confirm whether their tumors carry the NTRK gene fusion.

2. Usage and dosage

1.Dosage form and administration: Larotinib is usually used in the form of oral medication, and patients should take the medication correctly as recommended by their doctor. Medication dosage forms may vary depending on the patient's specific condition, and patients should obtain detailed dosing instructions at the pharmacy.

2.Dosage and frequency: The dosage and frequency of larotrectinib will be individually adjusted by the doctor based on the patient's condition, weight and other factors. Patients should strictly follow the doctor's instructions during medication and are not allowed to change the dosage or frequency on their own.

3.Taking before or after meals: The medication instructions for larotrectinib may contain specific recommendations on whether it needs to be taken before or after meals. Patients should read it carefully and follow the instructions.

3. Drug interactions

1.Other drugs: While using larotrectinib, patients should inform their doctor of all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Some drugs may interact with larotrectinib, affecting the drug's efficacy or increasing the risk of adverse reactions.

2.Food: Patients should avoid eating foods that interact with the drug while taking the drug, especially foods that contain drug-metabolizing enzymes. Your doctor may provide specific advice about diet.

4. Adverse reactions and warnings

1.Adverse reactions: The use of larotrectinib may cause some adverse reactions, including but not limited to fatigue, dizziness, nausea, etc. Patients should pay close attention to their physical condition during the medication and inform their doctor promptly if they feel uncomfortable.

2.Warnings: Doctors may explain some potentially serious adverse reactions and warnings to patients. Patients should understand this information and remain vigilant during medication. If any serious adverse reactions occur, seek medical attention immediately.

5. Pregnant and lactating women

1.Pregnant women: Pregnant women should inform their doctor before using larotrectinib because the drug may have an impact on the fetus. Your doctor will decide whether to continue using larotrectinib, weighing the potential benefits and risks.

2.Breastfeeding women: Whether larotrectinib can be passed through breast milk is unclear, so lactating women should consult their doctor while using the drug and decide whether to interrupt breastfeeding based on the specific situation.

6. Monitoring and follow-up

1.Regular examinations: During the medication period, the doctor may require the patient to undergo regular physical examinations, blood tests, etc. to monitor the efficacy of the medication and the patient's overall health.

2.Follow-up: Patients need to have regular follow-up visits as arranged by the doctor, and promptly report any discomfort or changes so that the doctor can adjust the treatment plan in a timely manner.

7. Other matters needing attention

1.Drug storage: Patients should store larotrectinib correctly in accordance with the drug instructions and avoid direct sunlight and high temperature.

2.Emergency treatment: Patients should understand the emergency treatment methods in emergency situations, including drug overdose, serious adverse reactions, etc.

In general, the use of larotrectinib needs to be carried out under the guidance of a professional doctor. Patients should carefully follow the doctor's instructions, pay close attention to their physical condition, and report any abnormalities to the doctor in a timely manner. During the medication process, adequate communication between patients and doctors is key to ensuring that treatment is safe and effective.

Larotrectinib has been launched in China and has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in hospitals. For specific conditions, it is recommended to consult the local hospital pharmacy. In foreign markets, larotinib has two options: original drug and generic drug. Original drugs include the German version, the American version, the European version and the Hong Kong version, and the price is about 10,000 to 20,000 yuan. In comparison, generic drugs are much cheaper. There are Lao and Bangladeshi versions of generic drugs, and the price is around two to three thousand. It is worth noting that the ingredients of original drugs and generic drugs are basically the same.